Clinically, the diagnosis, staging, and bone metastasis of PCa mainly rely on the detection of serum prostate-specific antigen (PSA) test in combination with imaging means such as CT, MRI, and systematic bone scans, which still have the risk of negative or false positive results [5]. This evidence concerns the gene KLK3 and posterior cortical atrophy.